Antileishmanial Activity of Niosomal Combination Forms of Tioxolone along with Benzoxonium Chloride against Leishmania tropica
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In this study, we carried out extensive in vitro studies on various concentrations of tioxolone along with ben- zoxonium chloride and their niosomal forms against Leishmania tropica. Niosomes were prepared by the hydration meth- od and were evaluated for morphology, size, release study, and encapsulation efficiency. This study measured leishmani- cidal activity against promastigote and amastigote, apoptosis and gene expression levels of free solution and niosomal- encapsulated tioxolone along with benzoxonium chloride. Span/Tween 60 niosome had good physical stability and high encapsulation efficiency (more than 97%). The release profile of the entrapped compound showed that a gradual release rate. The combination of niosomal forms on promastigote and amastigote were more effective than glucantime. Also, the niosomal form of this compound was significantly less toxic than glucantime (P ≤ 0.05). The flowcytometric analysis on niosomal form of drugs showed that higher number of early apoptotic event as the principal mode of action (89.13% in 200 μg/mL). Also, the niosomal compound increased the expression level of IL-12 and metacaspase genes and de- creased the expression level of the IL-10 gene, which further confirming the immunomodulatory role as the mechanism of action. We observed the synergistic effects of these 2 drugs that induced the apoptotic pathways and also up regulation of an immunomodulatory role against as the main mode of action. Also, niosomal form of this combination was safe and demonstrated strong anti-leishmaniasis effects highlights further therapeutic approaches against anthroponotic cutane- ous leishmaniasis in future planning.
Abstract
In this study, we carried out extensive in vitro studies on various concentrations of tioxolone along with ben- zoxonium chloride and their niosomal forms against Leishmania tropica. Niosomes were prepared by the hydration meth- od and were evaluated for morphology, size, release study, and encapsulation efficiency. This study measured leishmani- cidal activity against promastigote and amastigote, apoptosis and gene expression levels of free solution and niosomal- encapsulated tioxolone along with benzoxonium chloride. Span/Tween 60 niosome had good physical stability and high encapsulation efficiency (more than 97%). The release profile of the entrapped compound showed that a gradual release rate. The combination of niosomal forms on promastigote and amastigote were more effective than glucantime. Also, the niosomal form of this compound was significantly less toxic than glucantime (P ≤ 0.05). The flowcytometric analysis on niosomal form of drugs showed that higher number of early apoptotic event as the principal mode of action (89.13% in 200 μg/mL). Also, the niosomal compound increased the expression level of IL-12 and metacaspase genes and de- creased the expression level of the IL-10 gene, which further confirming the immunomodulatory role as the mechanism of action. We observed the synergistic effects of these 2 drugs that induced the apoptotic pathways and also up regulation of an immunomodulatory role against as the main mode of action. Also, niosomal form of this combination was safe and demonstrated strong anti-leishmaniasis effects highlights further therapeutic approaches against anthroponotic cutane- ous leishmaniasis in future planning.
참고문헌 (32)
- Cortez de Sá J, "Leishmanicidal, cytotoxicity and wound healing potential of Arrabidaea chica Verlot", BMC Complement Altern Med, 16, pp.1~ (2016)
- de Vries HJ, "Cutaneous leishmaniasis : recent developments in diagnosis and management", Am J Clin Dermatol, 16, pp.99~109 (2015)
- Plano D, "Selenocyanates and diselenides : a new class of potent antileishmanial agents", Eur J Med Chem, 46, pp.3315~3323 (2011)
- Sharifi F, "Spatial distribution and molecular identification of Leishmania species from endemic foci of south-eastern Iran", Iran J Parasitol, 7, pp.45~52 (2012)
- Kazi KM, "Niosome : a future of targeted drug delivery systems", J Adv Pharm Technol Res, 1, pp.374~380 (2010)
- Daie Parizi MH, "The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride(Thio-Ben)along with cryotherapy : A single-blind randomized clinical trial", Dermatol Ther, 28, pp.140~146 (2015)
- Ja Eun Kim, "LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression", Experimental and Molecular Medicine, 40(5), pp.514~522 (2008), 생화학분자생물학회
- Kim BH, "Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta", Mol Pharmacol, 73, pp.1309~1318 (2008)
- 김병학, "Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3", STAT3 signaling, 2011, pp.43(5), 313~321[DOI]
- Pardakhty A, "Preparation and evaluation of niosomes containing autoclaved Leishmania major : a preliminary study", J Microencapsul, 29, pp.219~224 (2012)
- Attia IA, "Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits", AAPS Pharm Sci Tech, 8, pp.206~212 (2007)
- Shahiwala A, "Studies in topical application of niosomally entrapped Nimesulide", J Pharm Pharm Sci, 5, pp.220~225 (2002)
- Chandra D, "Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage", monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism, 2008, pp.154, 224~234
- Satheesh Kumar S, "Comparative in-silico genome analysis of Leishmania(Leishmania)donovani : a step towards its species specificity", Meta Gene, 2, pp.782~798 (2014)
- Yasinzai M, "Drug resistance in leishmaniasis : current drug-delivery systems and future perspectives", Future Med Chem, 5, pp.1877~1888 (2013)
- Rahimpour Y, "Recent Advances in Novel Drug Carrier Systems 1", pp.141~164 (2012)
- Yasam VR, "A review on novel vesicular drug delivery : proniosomes", Drug Deliv, 21, pp.243~249 (2014)
- Barcinski MA, "Apoptosis in parasites and parasite-induced apoptosis in the host immune system : a new approach to parasitic diseases", Braz J Med Biol Res, 32, pp.395~401 (1999)
- Paris C, "Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes", Antimicrob Agents Chemother, 48, pp.852~859 (2004)
- Das R, "Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani", Apoptosis, 13, pp.867~882 (2008)
- Nguewa PA, "Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin", Chem Biodivers, 2, pp.1387~1400 (2005)
- Das M, "Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes", J Cell Sci, 114, pp.2461~2469 (2001)
- Weingärtner A, "Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment", PLoS One, 7, pp.e42070~ (2012)
- Basmaciyan L, "Calcein+", PI-as an early apoptotic feature in Leishmania, 2017, pp.12, e0187756~
- Hingorani R, "Detection of Apoptosis Using the BD Annexin V FITC Assay on the BD FACSVerseTM System", BD Biosciences, 1~12 (2011)
- Mera-Ramírez A, "Screening of TNFα, IL-10 and TLR4 single nucleotide polymorphisms in individuals with asymptomatic and chronic cutaneous leishmaniasis in Colombia : a pilot study", BMC Infect Dis, 17, pp.177~ (2017)
- Martorelli D, "Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders", Clin Dev Immunol, 3, pp.931952~ (2012)
- Bogdan C, "Macrophage deactivation by interleukln 10", J Exp Med, 174, pp.3~7 (1991)
- Ambit A, "An essential role for the Leishmania major metacaspase in cell cycle progression", Cell Death Differ, 15, pp.113~122 (2008)
- González IJ, "Leishmania major metacaspase can replace yeast metacaspase in programmed cell death and has arginine-specific cysteine peptidase activity", Int J Parasitol, 37, pp.161~172 (2007)
- Lee N, "Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania", Eukaryot Cell, 6, pp.1745~1757 (2007)
- Debrabant A, "Programmed cell death in trypanosomatids and other unicellular organisms", Int J Parasitol, 33, pp.257~267 (2003)